Amerigo Allegretto[email protected]Financial ResultsBio-Rad reports Q2 revenue drop, COVID-19 sales declineFor the three months ended June 30, the Hercules, CA-based firm reported a 52% drop in COVID-19 related revenues to approximately $33 million in Q2 from approximately $69 million in the year-ago period.July 28, 2022SequencingIllumina hits Guardant with lawsuit over trade secretsFiled in U.S. District Court for the District of Delaware, the lawsuit alleges that Eltoukhy and Talasaz had access to Illumina trade secrets while they were employed with Illumina up through 2013 and 2012, respectively. The lawsuit charges that the two incorporated Guardant in 2011 while still employed by Illumina and used Illumina technology as the basis for their new company.March 17, 2022Page 1 of 1Top StoriesGene silencing and gene editingEngineered Cas clears barrier to antiviral CRISPR therapiesResearchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.Artificial IntelligenceAI-powered endoscope doubles detection of high-risk esophageal lesionsMergers & AcquisitionsBruker to acquire NanoString for $392.6MTrends and FinanceDermTech receives delisting warning from NasdaqSponsor ContentVisit our Molecular Diagnostics Community
